0.00Open6.40Pre Close0 Volume2 Open Interest22.50Strike Price0.00Turnover0.00%IV10.95%PremiumDec 20, 2024Expiry Date4.42Intrinsic Value100Multiplier16DDays to Expiry1.98Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma4.58Leverage Ratio--Theta--Rho--Eff Leverage--Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet